Business Context and Reporting Period
Company: Ecovyst Inc. (ECVT)
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended December 31, 2024
Business Overview: Ecovyst is a global provider of advanced materials, specialty catalysts, and services, operating through two segments: Ecoservices (sulfuric acid recycling and virgin acid production) and Advanced Materials & Catalysts (silica catalysts and a 50% interest in the Zeolyst Joint Venture). The company focuses on sustainability-driven innovation, including clean fuels, emission control, and plastics recycling.
Key Financial Metrics
| Metric | 2024 | 2023 | Change |
|---|---|---|---|
| Total Sales | $704.5 million | $691.1 million | +1.9% |
| Gross Profit | $201.5 million | $197.9 million | +1.8% |
| Gross Margin | 28.6% | 28.6% | 0.0% |
| Operating Income | $98.0 million | $96.7 million | +1.3% |
| Net (Loss) Income | $(6.7) million | $71.2 million | Turn to Loss |
| Adjusted EBITDA | $238.2 million | $259.9 million | -8.3% |
| Operating Cash Flow | $149.9 million | $137.6 million | +9.0% |
| Total Debt | $870.8 million | $877.5 million | -0.8% |
| Cash & Equivalents | $146.0 million | $88.4 million | +65.2% |
| Total Liquidity | $221.2 million | $163.6 million | +35.2% |
Note: Total Liquidity includes cash and cash equivalents plus available borrowing capacity under the Asset-Based Lending (ABL) facility ($75.2 million).
Material Changes vs. Prior Period
- Net Loss vs. Net Income: The company reported a net loss of $6.7 million in 2024 compared to net income of $71.2 million in 2023. This reversal was primarily driven by a $65.0 million impairment charge on the investment in the Zeolyst Joint Venture (an equity method affiliate) and a $3.9 million intangible asset impairment charge.
- Segment Performance:
- Ecoservices: Sales increased 2.3% to $598.3 million, driven by higher volumes in regeneration services and virgin sulfuric acid, partially offset by lower average selling prices due to cost pass-throughs.
- Advanced Materials & Catalysts: Sales remained flat at $106.2 million. Adjusted EBITDA for this segment declined 21.0% to $64.7 million, largely due to lower earnings from the Zeolyst Joint Venture.
- Interest Expense: Net interest expense increased 10.5% to $49.4 million due to higher variable interest rates, partially offset by lower outstanding debt and spread reductions from a June 2024 refinancing.
- Capital Expenditures: Total capital expenditures increased to $69.4 million (from $62.2 million in 2023), with growth capex rising to $16.1 million, primarily for the Kansas City Advanced Silicas catalyst coating facility expansion.
Guidance, Outlook, Risks, and Unusual Items
- Strategic Review: The Board initiated a strategic review of the Advanced Materials & Catalysts segment in December 2024. This review may result in a disposition of all or part of the segment, though no decision has been made. Proceeds from any sale may be required to repay indebtedness.
- Impairment Drivers: The $65 million Zeolyst Joint Venture impairment was driven by a revised demand outlook for catalyst materials used in emission control and sustainable fuels production.
- Internal Control Material Weakness: Management identified a material weakness in internal control over financial reporting related to the accounting of the Zeolyst Joint Venture investment. Controls were deemed ineffective in ensuring earnings were completely, accurately, and timely recorded.
- Debt Refinancing: In June 2024, the company amended its Term Loan Facility to reduce interest rates and extend maturity to 2031. In January 2025, the facility was re-priced to further reduce rates (SOFR + 2.00%).
- Risks: Key risks include substantial indebtedness ($870.8 million), exposure to raw material price volatility (natural gas, sulfur), customer concentration (top 10 customers represent ~60% of sales), and potential disruptions from environmental regulations or geopolitical conflicts.
Investor Verification Checklist
- Zeolyst Joint Venture Valuation: Verify the assumptions used in the discounted cash flow and market approach models that led to the $65 million impairment charge.
- Internal Control Remediation: Monitor the progress of the remediation plan for the material weakness in internal controls regarding the Zeolyst investment accounting.
- Strategic Review Outcome: Track the status of the strategic review of the Advanced Materials & Catalysts segment for potential divestiture or restructuring.
- Debt Covenants: Confirm continued compliance with the fixed-charge coverage ratio and minimum availability covenants under the Term Loan and ABL facilities.
- Customer Concentration: Assess the impact of the top two customers (14% and 11% of sales) on future revenue stability, particularly in the Ecoservices segment.